United States Antimony (NYSE:UAMY) Hits New 52-Week Low - What's Next?

Key Points

• United States Antimony shares hit a new 52-week low, trading as low as $3.98 and last changing hands near $4.01. The stock is down from its 50-day and 200-day moving averages of $5.15 and $7.26, respectively.
• Analyst sentiment remains mixed but leans positive: HC Wainwright maintained a “buy” rating while cutting its price target to $9.25, and the broader analyst consensus is “Moderate Buy” with a $10.12 target.
• Insiders have been buying the stock, with executives and directors purchasing 62,700 shares worth about $298,592 over the past three months. Insiders own 5.5% of the company, while institutional investors hold 9.49%.

United States Antimony Co. (NYSE:UAMY - Get Free Report) hit a new 52-week low during mid-day trading on Monday. The company traded as low as $3.98 and last traded at $4.01, with a volume of 95681 shares. The stock had previously closed at $3.99.

Analysts Set New Price Targets

Several brokerages recently issued reports on UAMY. HC Wainwright reduced their price objective on shares of United States Antimony from $11.75 to $9.25 and set a "buy" rating on the stock in a report on Wednesday, August 12th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of United States Antimony in a research note on Monday, September 14th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $10.12.

United States Antimony Stock Down 2.9%

The firm has a market cap of $579.97 million, a PE ratio of -29.73 and a beta of 0.38. The company's fifty day moving average price is $5.15 and its two-hundred day moving average price is $7.26.

Insider Buying and Selling at United States Antimony

In other United States Antimony news, EVP Lloyd EVP, Chief Mining Officer, & Director acquired 20,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 1st. The shares were acquired at an average cost of $4.63 per share, for a total transaction of $92,600.00. Following the transaction, the executive vice president directly owned 932,881 shares of the company's stock, valued at approximately $4,319,239.03. This represents a 2.19% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph A. Carrabba bought 21,300 shares of the business's stock in a transaction on Tuesday, September 1st. The shares were acquired at an average price of $4.72 per share, with a total value of $100,536.00. Following the transaction, the director owned 198,401 shares of the company's stock, valued at $936,452.72. The trade was a 12.03% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders purchased 62,700 shares of company stock valued at $298,592. Corporate insiders own 5.50% of the company's stock.

Institutional Trading of United States Antimony

Institutional investors have recently made changes to their positions in the stock. KBC Group NV purchased a new stake in United States Antimony during the 1st quarter worth $31,000. Harbour Investments Inc. increased its stake in United States Antimony by 106.2% during the fourth quarter. Harbour Investments Inc. now owns 7,962 shares of the company's stock valued at $40,000 after purchasing an additional 4,101 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of United States Antimony by 799.3% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 15,054 shares of the company's stock worth $76,000 after purchasing an additional 13,380 shares during the period. Wealthfront Advisers LLC acquired a new stake in United States Antimony during the second quarter worth about $85,000. Finally, Geneos Wealth Management Inc. lifted its stake in United States Antimony by 17.9% in the first quarter. Geneos Wealth Management Inc. now owns 9,892 shares of the company's stock valued at $86,000 after buying an additional 1,500 shares during the last quarter. 9.49% of the stock is owned by hedge funds and other institutional investors.

United States Antimony Company Profile

United States Antimony Corporation, through its subsidiaries, produces and sells antimony, precious metals and related specialty materials. Its products include antimony oxide, antimony metal, sodium antimonate and other antimony compounds used in applications such as flame retardants, ceramics, glass, pigments, batteries and other industrial products.

The company also processes and refines antimony-bearing materials and recovers precious metals from selected raw materials and recyclable sources.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.